Menu
Synergy in Action

2021 Autumn Conference – Includes Joint Day with ECNP

Applications of Lessons Learned from 2020
30 September – 02 October, 2021   //   Virtual Conference

Distinguished Poster Award Recipient:

Placebo Response Propensity Scale (PRPS) scores and probability of placebo response by disease severity (Morlock)  

View all Poster PDFs and Abstracts 

 

30 September 2021

   
 Welcome from the President Ramy Mahmoud
slides slides
video
 
Session 1: Applications of Lessons Learned from 2020: Diversity in CNS clinical trials Chairs:
Carla Canuso
Jerry Sanacora
H. Lynn Starr
 
  Introduction

Carla Canuso
video
slides slides
 
  Why is diversity in clinical trials important?

David Henderson
slides slides
video
 
  How are we doing? One company’s assessment of diversity in clinical trials H. Lynn Starr
slides slides
video
 
  Putting new learnings and best practices into action Lionel Phillips
slides slides
 video
 
  The Yale model and our partnered approach: Increasing clinical trial representation through community collaboration and innovation Tesheia Harris
slides
slides
video
 
  Cultural adaptation frameworks and use of real world evidence in the study of diverse populations Shanaya Rathod
slides slides
video
 
  Recruitment and enrollment panel discussion Moderators:
Carla Canuso
Jerry Sanacora

video
 
  FDA OMHHE: Working to advance racial and ethnic minority participation in clinical trials Richardae Araojo
slides
slides
video
 
  Statistical approaches under heterogeneous treatment effects Mark Rothmann
slides
slides
video
 
  EMA Regulatory comment Florence Butlen-Ducuing
slides slides
video
 
  Discussion Regulatory speakers
video
 
  Session Summary Jerry Sanacora
Carla Canuso
video
 

 Poster Session

Poster PDFs and Abstracts  

 1 October 2021

 
 Welcome from the Presidents Gitte Knudsen
Ramy Mahmoud
slides slides
video
 
Session 2: Knowledge of COVID-19 biology / syndromes: How does it lead to new research considerations Chairs:
David Baldwin
Kemi Olugemo

 
  Introduction Kemi Olugemo
slides
slides
video
 
  COVID-19 and mental health: A global perspective

Christoph Correll*
slides slides
video
 
  Nature and course of psychological symptoms in the general population during the pandemic: Insights from national cross-sectional and longitudinal studies

Samuel Chamberlain*

 
  6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records Maxime Taquet 
slides
slides
video
 
  Early effects of the pandemic on individuals with serious mental illness: Findings from multisite Ecological Momentary Assessment (EMA) studies Raeanne Moore
slides
slides
video
 
  Panel discussion: Includes patient advocacy perspective Discussant:
Erik Van der Eycken
video
 
  Challenges for trial design and analysis during the pandemic era: Development of the CONSERVE statement Richard Emsley
slides 
slides
video
 
  Discussion – DeMartinis and Emsley

video

 
  Session Summary Kemi Olugemo
video
 
Session 3: Lessons learned for the good – Overcoming obstacles Chairs: 
Dragana Bugarski-Kirola
Gerard Dawson
 
  Introduction Gerard Dawson
slides
 slides
video
 
  COVID-19 lockdown conditions and depression assessment data from an exploratory MDD clinical trial Nicholas DeMartinis
slides slides
video
 
  Panel: Impact of COVID-19 pandemic on participants, operational aspects of clinical conduct and implication for data analysis    
  Introduction Dragana Bugarski-Kirola
video
 
  Impact of  COVID-19 pandemic on Seriously Mentally Ill (SMI) subjects in clinical trials Robert Litman
slides slides
video
 
  Case study of an Alzheimer’s disease (AD) international trial successfully initiated during the first wave of the COVID pandemic Joanne Bell
slides slides
video
 
  Clinical trial continuity in the wake of a pandemic

Ramzey Odetalla
slides 
slides
video
 
  Conducting a pediatric orphan (Tourette’s study pre & during COVID shutdown: Experience and lessons learned Atul Mahableshwarkar
slides
slides
video
 
  Panel Discussion Facilitator:
Gerard Dawson
video
 
  Impact of COVID-19 lockdown on data integrity and analysis of a transdiagnostic study with two patient populations Dennis Hernaus
slides
slides
video
 
  Panel: Regulatory discussants Discussants:
intro video
Valentina Mantua
slides slides
video
Lorenzo Guizzaro
slides
slides
video
 
  Panel Discussion All speakers
video
 
  Session Summary Gerard Dawson
video
 

 2 October 2021

 

Saturday Concurrent Working Group Sessions

   
  Innovative technologies for CNS clinical trials Chairs:
Richard Keefe
Michael Davis
 
  Joint ISCTM/ECNP COVID-19 methodologies blueprint Chairs:
Dragana Bugarski-Kirola
Gerard Dawson
Kemi Olugemo
 
  Orphan diseases Chairs:
Joan Busner
Gahan Pandina

 
  *Full presentation not released